Literature DB >> 3158297

Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B.

J R Guyton, G H Dahlen, W Patsch, J A Kautz, A M Gotto.   

Abstract

Lipoprotein Lp(a) is an atherogenic subfraction of plasma lipoproteins which has been studied predominantly in white populations. We quantified Lp(a) by electroimmunoassay in plasma from 105 black and 134 white healthy men and women. Results were correlated with clinical variables and plasma levels of lipids, other lipoproteins, and apolipoprotein (apo) B determined by radioimmunoassay. Black subjects had levels of Lp(a) that averaged twice those of whites (p less than 0.001). Among blacks, Lp(a) levels showed a bell-shaped frequency distribution, while among whites the distribution was strongly skewed, with the highest frequencies at low levels. Contrary to previously published results, the apo B levels in our study correlated significantly, though weakly, with Lp(a) (r = 0.21, p = 0.001 among whites, and r = 0.15, p = 0.02 among blacks, Kendall rank correlation). The regression slopes and variances suggested that apo B in the Lp(a) lipoprotein could account for the correlation. Lp(a) levels did not correlate significantly with any other plasma lipoprotein or lipid levels. The implications of this study are as follows: Despite the high levels of Lp(a) among blacks in the Houston area, these blacks do not experience greatly increased atherosclerotic progression and mortality. Thus, the atherogenicity of Lp(a) in blacks must be decreased or counterbalanced by other factors. The correlation between Lp(a) and apo B should be taken into account when analyzing atherogenic risk, but this correlation is not strong enough to dispute the independence of Lp(a) and apo B as risk factors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158297     DOI: 10.1161/01.atv.5.3.265

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  32 in total

Review 1.  Lipoprotein(a): an elusive cardiovascular risk factor.

Authors:  Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

2.  The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans.

Authors:  V Mooser; D Scheer; S M Marcovina; J Wang; R Guerra; J Cohen; H H Hobbs
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

3.  Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Lars Berglund
Journal:  Atherosclerosis       Date:  2014-05-10       Impact factor: 5.162

Review 4.  Lipoprotein (a). Heterogeneity and biological relevance.

Authors:  A M Scanu; G M Fless
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

5.  Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Weihua Guan; Jing Cao; Brian T Steffen; Wendy S Post; James H Stein; Mathew C Tattersall; Joel D Kaufman; Joseph P McConnell; Daniel M Hoefner; Russell Warnick; Michael Y Tsai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02-19       Impact factor: 8.311

6.  Linkage between the loci for the Lp(a) lipoprotein (LP) and plasminogen (PLG).

Authors:  L R Weitkamp; S A Guttormsen; J S Schultz
Journal:  Hum Genet       Date:  1988-05       Impact factor: 4.132

7.  Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus.

Authors:  A Gaw; E Boerwinkle; J C Cohen; H H Hobbs
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

8.  Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).

Authors:  Margaret R Diffenderfer; Stefania Lamon-Fava; Santica M Marcovina; P Hugh R Barrett; Julian Lel; Gregory G Dolnikowski; Lars Berglund; Ernst J Schaefer
Journal:  Metabolism       Date:  2015-11-06       Impact factor: 8.694

9.  Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma.

Authors:  P Henriksson; B Angelin; L Berglund
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

10.  TESTING POPULATION-SPECIFIC QUANTITATIVE TRAIT ASSOCIATIONS FOR CLINICAL OUTCOME RELEVANCE IN A BIOREPOSITORY LINKED TO ELECTRONIC HEALTH RECORDS: LPA AND MYOCARDIAL INFARCTION IN AFRICAN AMERICANS.

Authors:  Logan Dumitrescu; Kirsten E Diggins; Robert Goodloe; Dana C Crawford
Journal:  Pac Symp Biocomput       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.